Today: 1 July 2026
Browse Category

NYSE:TSM 17 January 2026 - 27 January 2026

TSMC stock price set for a Monday test after Taiwan talks up more Arizona chip investment

TSMC stock price set for a Monday test after Taiwan talks up more Arizona chip investment

Taipei, Jan 25, 2026, 07:35 — Market closed. Taiwan Semiconductor Manufacturing Co’s shares closed modestly higher in Taipei on Friday. Its U.S.-listed ADRs, which represent the same foreign shares in New York, jumped over 2% as the weekend approached. TSMC ended the day at NT$1,770, up 0.57%, while TSM finished at $334.87, gaining roughly 2.3%.
25 January 2026
···
TSMC stock: Taiwan shares close at NT$1,740 as capex push and Arizona plans steer next week

TSMC stock: Taiwan shares close at NT$1,740 as capex push and Arizona plans steer next week

TAIPEI, Jan 18, 2026, 06:30 — Market closed Taiwan Semiconductor Manufacturing Co’s shares jumped 2.96%, closing at a peak of NT$1,740 on Friday. This surge helped push Taiwan’s Taiex index to a record high. “These figures simply told investors AI demand is robust,” said Alex Huang of Mega International Investment Services, noting the company's forecast of nearly 30% sales growth for 2026 and a capex plan reaching $56 billion for factories and equipment.
17 January 2026
·
Nvidia stock’s next test: Trump’s AI chip tariff meets China’s H200 roadblock

Nvidia stock’s next test: Trump’s AI chip tariff meets China’s H200 roadblock

New York, Jan 17, 2026, 13:02 EST — The market has closed. Nvidia and AMD shares face a new hurdle next week after President Donald Trump signed a proclamation slapping a 25% tariff on some advanced computing chips, including Nvidia’s H200 AI processor and AMD’s MI325X. South Korea’s trade minister noted the tariff targets “advanced chips made by Nvidia and AMD.”
17 January 2026
······
1 2 3 4 5 6 … 12

Stock Market Today

  • ASX 200 trails global indexes in 2026 as key healthcare names dive
    July 1, 2026, 3:42 AM EDT. The ASX 200 barely managed a gain of less than 2.8% for the 2026 financial year, outpaced by major overseas markets. The rise was negative after inflation. US stocks soared, with the S&P 500 up 20.8%, NASDAQ up 28.7%, and Europe's STOXX 600 climbing 19%. Losses for CSL-off 52%-and Cochlear, down almost 60%, weighed on the Australian market. Bank results were mixed; ANZ gained 16% but Commonwealth Bank and NAB lagged. 4D Medical stood out with strong returns while the rest of the market barely moved.
Go toTop